Filing Details

Accession Number:
0001437749-20-019683
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-14 17:11:37
Reporting Period:
2020-09-10
Accepted Time:
2020-09-14 17:11:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1384101 Veracyte Inc. VCYT Services-Medical Laboratories (8071) 205455398
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1588970 H Bonnie Anderson 6000 Shoreline Court
Suite 300
South San Francisco CA 94080
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-10 20,000 $8.86 240,231 No 4 M Direct
Common Stock Disposition 2020-09-10 13,393 $30.61 226,838 No 4 S Direct
Common Stock Disposition 2020-09-10 6,607 $31.47 220,231 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2020-09-10 20,000 $0.00 20,000 $8.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
148,312 2025-03-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 99,085 Indirect TheBonnie H.AndersonLivingTrust
Common Stock 25,000 Indirect The ANPAndersonTrust
Common Stock 25,000 Indirect MJPAndersonTrust
Footnotes
  1. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.
  2. Represents weighted average sales price. Sale prices for the transactions range from $30.11 to $31.11. Detailed information regarding the number of shares sold at each separate price will be provided to theSEC, the issuer or a shareholder upon request.
  3. Represents weighted average sales price. Sale prices for the transactions range from $31.12 to $31.95. Detailed information regarding the number of shares sold at each separate price will be provided to theSEC, the issuer or a shareholder upon request.
  4. The Reporting Person disclaims beneficial ownership of the shares held by the Trust except to the extent of her pecuniary interest therein, if any.
  5. The option is fully vested.